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Jeune asphyxiating thoracic dystrophy (ATD) is an autosomal-recessive chondrodysplasia characterized by short ribs and a narrow
thorax, short long bones, inconstant polydactyly, and trident acetabular roof. ATD is closely related to the short rib polydactyly
syndrome (SRP) type III, which is a more severe condition characterized by early prenatal expression and lethality and variable malfor-
mations.We ﬁrst excluded IFT80 in a series of 26 fetuses and children belonging to 14 families diagnosed with either ATD or SRP type III.
Studying a consanguineous family fromMorocco, wemapped an ATD gene to chromosome 11q14.3-q23.1 in a 20.4Mb region and iden-
tiﬁed homozygous mutations in the cytoplasmic dynein 2 heavy chain 1 (DYNC2H1) gene in the affected children. Compound hetero-
zygosity for DYNC2H1mutations was also identiﬁed in four additional families. Among the ﬁve families, 3/5 were diagnosed with ATD
and 2/5 included pregnancies terminated for SRP type III. DYNC2H1 is a component of a cytoplasmic dynein complex and is directly
involved in the generation and maintenance of cilia. From this study, we conclude that ATD and SRP type III are variants of a single
disorder belonging to the ciliopathy group.Jeune asphyxiating thoracic dystrophy (ATD [MIM
208500]) is an autosomal-recessive chondrodysplasia char-
acterized by short ribs and respiratory insufﬁciency and is
often fatal in the ﬁrst year of life. Retinal degeneration,
cystic renal disease, and liver involvement occasionally
occur in the course of the disease. Mutations in the intra-
ﬂagellar transport 80 (IFT80 [MIM 611177]) gene have
been recently identiﬁed in 3/39 families originating from
Pakistan and Turkey, ascribing ATD to the ciliopathy
group.1 ATD is known to be genetically heterogeneous
with another locus mapped on chromosome 15q13.2
ATD is closely related to the short rib polydactyly group,
especially to the type III (SRP type III, also called Verma-
Naumoff, [MIM 263510]). Both conditions share the
same radiological features (including the polydactyly),
but SRP type III is more severe, characterized by an early
prenatal expression and lethality, variable malformations
(cleft lip and/or palate; polycystic kidneys; gastrointes-
tinal, urogenital, brain, and/or cardiac malformations),
and severely shortened tubular bones having round meta-
physeal ends with lateral spikes.3,4 Here, we report the
mapping of a locus on chromosome 11q and the identiﬁca-
tion of cytoplasmic dynein 2 heavy chain 1 (DYNC2H1
[MIM 603297]) mutations in ﬁve families with ATD or
SRP type III, supporting the view that ATD is an heteroge-
neous disorder overlapping with SRP type III and belongs
to the ciliopathy group.5706 The American Journal of Human Genetics 84, 706–711, May 15Criteria for inclusion in the study were (1) short ribs and
a constricted thoracic cage, (2) trident acetabular roof, (3)
small hands and feet, and (4) shortening of the long bones.
Included were a total of 15 children (ranging in age from
0 to 19 years of age) and 11 fetuses belonging to 14 fami-
lies, diagnosed with either ATD (15 living children and
four fetuses) or SRP type III (seven fetuses). Among the
fetuses, the diagnosis of SRP (rather than ATD) was as-
signed on the basis of the extreme severity of the thorax
narrowness and the long bone shortness with the presence
of metaphyseal spikes. Among all families with ATD or SRP
type III, six originating from Tunisia, Turkey, Portugal, and
Morocco were consanguineous. Blood samples from
patients and unaffected relatives were obtained with the
appropriate written consent, in accordance with the
French ethical standards regarding human subjects.
We ﬁrst excluded IFT80 either by linkage analysis in
consanguineous families with the use of microsatellite
markers or by direct sequencing in isolated cases (data
not shown).
We then focused on a large consanguineous Moroccan
family with two affected children (Figure 1). We performed
a genome-wide search, using the GeneChip Human
Mapping 250K NspI array (Affymetrix) on DNA samples
of the two affected children and one parent. Array experi-
ments were performed according to protocols provided by
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Figure 1. Pedigrees of the Five Affected Families and Segregation of the DYNC2H1 Mutationsthe software Affymetrix. We found a large region of homo-
zygosity shared by the two children on chromosome 11
(Figure S1, available online). Using the MERLIN program,
we found a maximum LOD score (Z ¼ 3, at q ¼ 0) for the
region delimited by SNP markers rs921561 and
rs1893996. Further analyses with polymorphic microsatel-
lite markers allowed us to delineate the critical region, the
centromeric boundary deﬁned by marker D11S4175 and
the telomeric boundary by marker D11S1893 (11q14.3-
11q23.1, 20.4 Mb).
This region encompasses 85 genes, and among them, we
ﬁrst considered the genes referenced in the cilia database
(see Web Resources), namely KDEL (Lys-Asp-Glu-Leu) con-
taining 2 (KDELC2); Ras-related protein Rab-39A (Rab-39);
guanylate cyclase 1, soluble, alpha 2 (GUCY1A2 [MIM
601244]); and cytoplasmic dynein 2 heavy chain 1
(DYNC2H1). After having excluded the ﬁrst three genes
by direct sequencing, we considered DYNC2H1 as a good
candidate gene because it encodes a subunit of a cyto-
plasmic dynein complex.5 This gene is composed of 90
exons and encodes a protein of 4314 amino acids. We per-The Amformed direct sequencing, using 90 couples of primers
(Table S1), and identiﬁed two homozygous missense muta-
tions in the two affected children (p.Met1991Leu;
p.Met3762Val, Table 1). The mutations cosegregated with
the disease and were not identiﬁed in 210 control chromo-
somes from the same ethnic origin (Figure 1). With the use
of the PolyPhen web program,6 the consequences of these
two mutations were predicted as benign for the
p.Met1991Leu mutation and as probably damaging for
the p.Met3762Val mutation. However, the p.Met1991Leu
mutation is located in the P-loop NTPase domain, whereas
the p.Met3762Val mutation is located in a region of
unknown function. It is therefore difﬁcult to speculate
on the responsibility of one rather than the other muta-
tion. Moreover, whether the disease is the consequence
of only one of these two mutations or of their combined
effect remains questionable.
The DYNC2H1 locus was excluded in the other ﬁve
consanguineous families, but direct sequencing in eight
nonconsanguineous families identiﬁed DYNC2H1 muta-
tions in four of the families (Figure 1). Mutations wereerican Journal of Human Genetics 84, 706–711, May 15, 2009 707
Table 1. DYNC2H1 Mutations Identified in the Five Families with ATD or SRP Type III
Family (Diagnosis) Nucleotide Change Amino Acid Change Location Domain
Family 1 (ATD) c.[5971A/T,11284A/G]
homozygote
p.[Met1991Leu] Exon 38 P-loop NTPase
c.[5971A/T, 11284A/G]
homozygote
p.[Met1991Leu] Exon 78 unknown
Family 2 (ATD) c.[654_655insTTTATAACTTGGACA
GTCTATCCTTACTA]þ[9044A/G]
p.[Glu219Leu fsX2]þ[Asp3015Gly] Exon 5þExon 57 dynein heavy chain, N-terminal
region 1/ coiled-coil domain
Family 3 (SRP III) c.[4610A/G]þ[7382G/T] p.[Gln1537Arg]þ [Gly2461Val] Exon 30þExon45 Walker A motif/ unknown
Family 4 (ATD) c.[3719T/C]þ[10063G/T] p.[Ile1240Thr]þ [Gly3355X] Exon 25þExon 66 Dynein heavy chain,
N-terminal region 2/ unknown
Family 5 (SRP III) c.[5959A/G]þ [10130delT] p.[Thr1987Ala]þ[Leu3377CysfsX34] Exon 38þExon 67 P-loop NTPase/ Dynein
heavy chain, cytoskeleton regionpresent at the compound heterozygote state (Table 1), co-
segregated with the disease, and were absent in 210 control
chromosomes. Among the ten mutant genotypes, three
were premature stop codon mutations and seven were
missense mutations. The mutations were located
throughout the gene. Of the seven missense mutations,
six involved conserved amino acids across species
(Met1991, Gln1537, Thr1987, Gly2461, Asp3015,
Met3762; Figure 2). Apart from the Met1991 change, all
of the mutations were predicted as probably damaging by
the PolyPhen program.6
Although no tridimensional structural templates were
available, we modelized a short region of DYNC2H1 (resi-
dues Ile2967 to Val3137), using the microtubule-binding
domain (MTBD) from mouse cytoplasmic dynein 1 heavy
chain 1 (dync1h1) as a template.7 The 34% degree of
alignment sequence identity between DYNC2H1 and
the MTBD of dync1h1 was sufﬁcient for homology
modeling. The modelized region of DYNC2H1 is located
between AAA5 (a non-nucleotide-binding AAAþ domain)
and the dynein heavy chain domain. This region corre-708 The American Journal of Human Genetics 84, 706–711, May 15,sponds to the MTBD, part of the ﬂexible coiled-coil
region of the template, suggesting a possibly important
functional role of this region. No experimental evidence
was available for analysis of the functional impact of
the p.Asp3015Gly mutation. We therefore used the
program Swiss-Pdb Viewer 3.7 to compute possible
hydrogen bonds on the bases of atom distances, atom
angle, and atom types (O. Lund et al., 2002, CASP 5 con-
ferenceA102 abstract; ref. 8) and found that Asp3015 can
interact with Asn3070 (Figure 3). The p.Asp3015Gly
mutation is expected to disrupt this hydrogen bond and
to compromise the stability of the two a helices. We
therefore speculate that this conformational change
may alter the DYNC2H1 microtubule-binding capacity.
To predict the putative impact of the other missense
mutations on DYNC2H1 structure and function, we
used the secondary structure prediction methods avail-
able on the Network Protein Sequence Analysis (NPS@)
web server.9 The p.Ile1240Thr mutation localized in the
dynein heavy chain, N-terminal region 2 and the
p.Thr1987Ala and p.Met1991Leu mutations localized inFigure 2. Location of the DYNC2H1 Mutations2009
the P loop NTPase are predicted to be in a helices. The
p.Gln1537Arg and p.Gly2461Val mutations are localized,
respectively, in the Walker A motif and in a nonconserved
domain, and both are predicted to be in a random coil.
Taken altogether, these data suggest that the six missense
mutations may induce local conformational changes
altering the function of DYNC2H1.
We report here the identiﬁcation of DYNC2H1 muta-
tions in ﬁve distinct families with either ATD or SRP type
III (Table 2 and Figures 4 and 5). Interestingly, while the
Figure 3. Tridimensional Structure Model of a DYNC2H1
Putative Microtubule-Binding Domain Via Swiss-Pdb Viewer
3.7 Representation
The modeled protein is represented in orange and is superimposed
with the template (PDB code: 3err) shown in gray. Between
Asp3015 (in red) and Asn3070 (in green), a putative hydrogen
may be computed. The mutation p.Asp3015Gly disrupts this stabi-
lizing hydrogen bond, inducing a local conformational change
altering the function of this putative microtubule-binding
domain.The Amsubmission of our manuscript was being processed,
a similar paper was published by Merrill et al., reporting
DYNC2H1 mutations in three families with SRP type III.10
Our ﬁndings further support the view that ATD and SRP
type III are allelic disorders and belong to the same spec-
trum. ATD and SRP type III have been previously reported
in the same family.4 Moreover, the same histological
anomalies at the growth plate level have been reported
in the two disorders, also suggesting that these conditions
are variants of a single disorder, with SRP type III being at
the more severe end of the spectrum (Figure 5).11 In the
SRP cases (four fetuses belonging to families 3 and 5), the
diagnosis was made antenatally (before 20 weeks of gesta-
tion [wg]). Postaxial polydactyly of the hands was present
in one case (family 3 case), and other malformations
included renal tubular microcysts, hepatic biliary hyper-
plasia (case 3), and unexplained ascites (case 1, family 5).
The three ATD families included a total of ﬁve affected
cases. In family 1, one child died of respiratory distress
and pregnancy of her aunt was terminated at 28 wg for
severe narrowing of the thorax. In family 2, two pregnan-
cies were terminated for severe narrowing of the thorax,
one at 28 wg and on at 26 wg. Finally, the family 4 case,
the only survivor, is now 19 years old, and no eye, liver,
or kidney manifestations have been hitherto detected.
This wide clinical variability prompted us to search for
genotype-phenotype correlation. We identiﬁed a majority
of missense mutations (7/10) in both ATD and SRP, as well
as three nonsense mutations, also occurring in both ATD
and SRP, with no obvious correlation between genotype
and phenotype. The absence of homozygous nonsense
mutations supports a partial loss of DYNC2H1 function.
The same ﬁndings have been observed in the three ATD
cases as a result of IFT80 mutations—two missense muta-
tions and one in-frame deletionmutation have been found
so far.1
The ﬁnding of DYNC2H1 mutations in ATD and SRP
type III gives strong support to the view that these condi-
tions belong to the ciliopathy group, as previouslyTable 2. Clinical Features of the Five Families with DYNC2H1 Mutations
Family Origin CS
Age of Affected
Patient(s) Diagnosis Polydactyly
Kidney
Anomaly
Liver/Pancreas
Microscopic Changes
Other
Features
1 Morocco Yes Case 1: Death at day 2 ATD No No No No
1 Morocco Yes Case 2 : TP at 28 wg ATD No No No No
2 France No Case 1: TP at 28 wg ATD No No No No
2 France No Case 2: TP at 24 wg ATD No No No No
3 France No Case 1: TP at 25 wg SRP type III Postaxial
and Bilateral
Tubular
microcysts
Hepatic biliary, hyperplasia,
periduodenal pancreas
Anal anteposition,
micropenis
4 France No Case 1: 19 years ATD No No No No
5 Madagascar No Case 1: TP at 24 wg SRP type III No No No Ascites
5 Madagascar No Case 2 : TP at 22 wg SRP type III No No No No
5 Madagascar No Case 3 : TP at 16 wg SRP type III No No No No
CS denotes consanguinity, TP denotes terminated pregnancy, wg denotes weeks of gestation.erican Journal of Human Genetics 84, 706–711, May 15, 2009 709
suggested by the discovery of IFT80 mutations in ATD.
DYNC2H1 is a component of the cytoplasmic dynein
complex, DYNC2, in association with the light interme-
diate chain (DYNC2LI1) and is directly involved in the
contacts and translocation of the dynein complex along
microtubules via its large motor domain.12 Moreover, in
mammalian tissues, the colocalization of DYNC2H1,
DYNC2LI1, and IFT pathway homologs supports a speciﬁc
role in the generation and maintenance of mammalian
cilia. Primary cilia and IFT proteins have been shown to
be components of morphogenetic pathways (including
Hedgehog and Wnt pathways) essential for skeletal devel-
opment, and IFT proteins have been shown to be
involved in chondrocyte maturation through bone
morphogenetic protein (BMP) signaling.13,14 The ﬁndings
of DYNC2H1 mutations in ATD and SRP type III give
support to the role of cilia and IFT proteins in endochon-
dral bone formation. The presence of polydactyly also
suggests a requirement for DYNC2H1 in Sonic Hedgehog
signaling.15
Figure 4. Radiological Findings in the
Families with DYNC2H1 Mutations
(A) ATD cases. a and b: case 1 (day 2) from
family 1; c: case 1 (28 wg) from family 2;
d and e: affected child (4 mo) from family
4. Note the short bones, narrow thorax,
and trident aspect of the acetabular roof
(c, arrow). Note also the advanced prox-
imal femoral ossification in the family 4
case (e).
(B) SRP cases. a–c: terminated pregnancy
at 25 wg from family 3; d–f: case 1 from
family 5. Note the severe shortness of the
long bones, the narrow thorax, and the
trident aspect of the acetabular roof.
Note also the round metaphyseal ends
with lateral spikes (c, arrows), the tripli-
cate calcaneum (d, arrow), and the post-
axial polydactyly (a, arrow).
Note the bowing of the femora observed in
the cases from families 1–3 and 5 (Ab, Ac,
Bc, Bd).
In conclusion, this study demon-
strates that ATD and SRP type III
belong to the same heterogeneous
spectrum of conditions caused by
either IFT80 or DYNC2H1 mutations
and suggests a role for altered primary
cilium function in these disorders.
Yet, the presence of nine families
with ATD and/or SRP type III
unlinked to IFT80 and DYNC2H1
supports the genetic heterogeneity
of this condition. Ongoing studies
will hopefully lead to identiﬁcation
of other disease gene(s) presumably also involved in
primary cilia function.
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Web Resources
The URLs for data presented herein are as follows:
Cilia database: ExPASy, http://www.expasy.ch/sprot/; Zebraﬁsh
and comparative genomics blast, http://danio.mgh.harvard.
edu/blast/blast_grp.html710 The American Journal of Human Genetics 84, 706–711, May 15, 2009
Ensembl Human Genome server, http://ensembl.org/
MultAlin, http://bioinfo.genotoul.fr/multalin/
NetworkProteinSequenceAnalysis (NPS@),http://npsa-pbil.ibcp.fr/
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim/
PolyPhen, http://genetics.bwh.harvard.edu/pph/
Primer3, http://frodo.wi.mit.edu/
University of California, Santa Cruz (UCSC) Genome Browser,
http://genome.ucsc.edu/
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